4004 ESC Guidelines label use of medication should be limited to situations where it is in
the patient’s interest to do so, with regard to the quality, safety, and efficacy of care, and only …

The ‘Lambeth Conventions’ is a guidance document, written in 1987 (Walker et al., 1988),
intended to be of practical value in the investigation of experimental arrhythmias induced by …

Implantable cardioverter defibrillator (ICD) implantation carries a significant risk of
complications, however published estimates appear inconsistent. We aimed to present a …

Aims The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the
conventional transvenous ICD system to minimize intravascular lead complications. There are …

Background : The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) is the
first implantable defibrillator that avoids placing electrodes in or around the heart. Two large …

Background The subcutaneous implantable cardioverter–defibrillator (ICD) was designed to
avoid complications related to the transvenous ICD lead by using an entirely extrathoracic …

Background : The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads. The …

Background: The subcutaneous (S) implantable cardioverter-defibrillator (ICD) is safe and
effective for sudden cardiac death prevention. However, patients in previous S-ICD studies …

Brugada syndrome (BrS) is a cardiac arrhythmia disorder associated with sudden death in
young adults. With the exception of SCN5A, encoding the cardiac sodium channel Na V 1.5, …

Aims Anecdotal observations suggest that sub-clinical electrophysiological manifestations
of arrhythmogenic right ventricular cardiomyopathy (ARVC) develop before detectable …